A Study to Evaluate Multi-dose of HB0034 in Healthy Adult Participants
Clinical trial NCT05460455 · COMPLETED
Trial details
- NCT number
- NCT05460455
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2023-06-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.